Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Gastroretentive Drug Delivery Systems Outsourcing Market Growth Evolved From 2024 To 2025, And What’s Ahead?
In recent years, the market size for outsourced gastroretentive drug delivery systems has seen substantial growth. The market is predicted to increase from $1.39 billion in 2024 to $1.49 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period is due to several factors including an increase in stomach and small intestine disorders, an upturn in drug delivery systems, a surge in gastric cancer cases, increased government initiatives, and a rise in the number of hospitals.
In the coming years, the outsourcing market for gastroretentive drug delivery systems is projected to experience robust growth. The market is anticipated to reach $1.98 billion by 2029, progressing at a Compound Annual Growth Rate (CAGR) of 7.4%. Factors driving this growth during the prediction period include an upsurge in ambulatory centers, prioritization of patient compliance and convenience, the escalating occurrence of chronic diseases, the surge in personalized medication, and expanding elderly population. Key trends for the forecast period encompass advancements in polymer science, evolutions in formulation technologies and bioadhesive systems, the introduction of novel polymers and drug release modifiers, the creation of gastroretentive dosage forms, the incorporation of digital health technologies, intelligent gastroretentive systems, and targeted drug delivery.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Gastroretentive Drug Delivery Systems Outsourcing Market?
Increasing incidences of gastrointestinal diseases are projected to boost the expansion of the gastroretentive drug delivery systems outsourcing market in the future. Gastrointestinal disorders encompass various ailments that affect the digestive system, including the stomach, liver, gallbladder, intestines, and pancreas. The upsurge in these disorders can be attributed to an aging population, the use of antibiotics, infectious diseases, alterations in diet, stress and lifestyle changes, and obesity. By outsourcing gastroretentive drug delivery systems, pharmaceutical firms are able to harness the necessary expertise and resources to combat the rising threat of gastrointestinal disorders, thereby enhancing patient outcomes and their quality of life. For example, in January 2023, the American Cancer Society (ACS), a health organization based in the US and committed to eradicating cancer, reported an increase of 3.18% in gastrointestinal cancers, with the number rising to 348,840 from 338,090 in 2021 within the United States. Consequently, the escalating occurrence of gastrointestinal disorders is fueling the growth of the gastroretentive drug delivery systems outsourcing market.
Which Key Market Segments Comprise the Gastroretentive Drug Delivery Systems Outsourcing Market and Drive Its Revenue Growth?
The gastroretentive drug delivery systems outsourcingmarket covered in this report is segmented –
1) By Type: Floating Systems; Bioadhesive Systems; Other Types
2) By Dosage Form: Tablets; Liquid; Microspheres; Capsule; Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD); Neurological Disorders; Other Applications
4) By End User: Pharmaceutical Companies; Contract Research Organizations (CROs); Other End Users
Subsegments:
1) Floating Systems: Single Unit Systems; Multiple Unit Systems
2) Bioadhesive Systems: Hydrogels; Mucoadhesive Polymers
3) Other Types: Magnetically Assisted Systems; High-Density Systems; Osmotic Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp
Which Areas Are Leading Regions in the Gastroretentive Drug Delivery Systems Outsourcing Market Expansion Across the Globe?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Strategic Trends Steering theGastroretentive Drug Delivery Systems Outsourcing Market Direction?
Leading businesses in the gastroretentive drug delivery systems outsourcing market are concentrating on creating pioneering products such as ready-to-fill (RTF) colon functional capsules. These aim to increase the effectiveness of drug delivery and improve the convenience of patients. RTF colon functional capsules are pre-fabricated, empty capsules ready to be filled with specific formulations or active ingredients for the colon. For instance, in Germany, Evonik, a frontrunner in advanced drug delivery, rolled out their EUDRACAP colon functional capsules in September 2024. These capsules are crafted for the targeted delivery of oral medications to the ileo-colonic region and are the first RTF option on the market intended for delivering sensitive active ingredients like live biotherapeutic products (LBPs). They are currently available in technical grade, with a GMP-grade product in the pipeline. The development of EUDRACAP colon simplifies the formulation and speeds up time to market in the oral drug development process, marking a significant breakthrough in gastroretentive drug delivery systems.
View the full report here:
How Is the Gastroretentive Drug Delivery Systems Outsourcing Market Conceptually Defined?
Gastroretentive drug delivery systems outsourcing refers to the practice of pharmaceutical companies contracting with external service providers or contract research organizations (CROs) to develop and manufacture drug delivery systems designed to prolong the residence time of medications within the gastrointestinal (GI) tract. These systems are engineered to enhance drug absorption, improve therapeutic efficacy, and optimize patient outcomes.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15813
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model